Daniel B. Hoch, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 21 | 2021 | 3288 | 1.690 |
Why?
|
| Quality of Health Care | 5 | 2021 | 4321 | 0.820 |
Why?
|
| Anticonvulsants | 7 | 2019 | 1906 | 0.800 |
Why?
|
| Seizures | 13 | 2020 | 2954 | 0.650 |
Why?
|
| Medical Records | 3 | 2017 | 1407 | 0.540 |
Why?
|
| Neurology | 3 | 2015 | 780 | 0.480 |
Why?
|
| Self-Help Groups | 2 | 2005 | 192 | 0.430 |
Why?
|
| Patient Education as Topic | 6 | 2008 | 2315 | 0.430 |
Why?
|
| Electroencephalography | 16 | 2020 | 6237 | 0.370 |
Why?
|
| Perception | 1 | 2016 | 1198 | 0.340 |
Why?
|
| Mind-Body Therapies | 1 | 2012 | 279 | 0.310 |
Why?
|
| Internet | 4 | 2012 | 3090 | 0.310 |
Why?
|
| Physician-Patient Relations | 3 | 2016 | 3239 | 0.310 |
Why?
|
| Vocabulary, Controlled | 1 | 2008 | 167 | 0.290 |
Why?
|
| Computer-Assisted Instruction | 2 | 2008 | 362 | 0.280 |
Why?
|
| Telemedicine | 3 | 2021 | 3050 | 0.280 |
Why?
|
| Counseling | 1 | 2015 | 1538 | 0.280 |
Why?
|
| Consumer Health Information | 1 | 2008 | 215 | 0.260 |
Why?
|
| Drug Prescriptions | 1 | 2015 | 1669 | 0.250 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2218 | 0.240 |
Why?
|
| User-Computer Interface | 1 | 2008 | 1397 | 0.200 |
Why?
|
| Epilepsy, Temporal Lobe | 3 | 2016 | 389 | 0.190 |
Why?
|
| Epilepsies, Partial | 3 | 2018 | 431 | 0.190 |
Why?
|
| Electronic Mail | 1 | 2003 | 213 | 0.180 |
Why?
|
| Physician's Role | 2 | 2005 | 917 | 0.180 |
Why?
|
| Computer Communication Networks | 1 | 2001 | 293 | 0.160 |
Why?
|
| Medical Informatics | 2 | 2004 | 732 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7389 | 0.150 |
Why?
|
| Memantine | 1 | 2018 | 108 | 0.150 |
Why?
|
| Information Services | 1 | 1999 | 236 | 0.150 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2016 | 46 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4488 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2018 | 446 | 0.130 |
Why?
|
| Massachusetts | 3 | 2021 | 8833 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 4058 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2001 | 1386 | 0.120 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 909 | 0.120 |
Why?
|
| Adult | 24 | 2021 | 220969 | 0.120 |
Why?
|
| Automobile Driving | 1 | 2019 | 441 | 0.120 |
Why?
|
| Young Adult | 12 | 2020 | 59179 | 0.110 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 1984 | 63 | 0.110 |
Why?
|
| Documentation | 1 | 2020 | 895 | 0.110 |
Why?
|
| Cerebral Infarction | 1 | 2018 | 980 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2020 | 7960 | 0.110 |
Why?
|
| Hippocampus | 5 | 1986 | 3761 | 0.100 |
Why?
|
| Female | 28 | 2021 | 392148 | 0.100 |
Why?
|
| Monitoring, Physiologic | 3 | 2018 | 1779 | 0.090 |
Why?
|
| Middle Aged | 19 | 2021 | 220584 | 0.090 |
Why?
|
| Male | 28 | 2021 | 360358 | 0.090 |
Why?
|
| Chorea | 1 | 2011 | 79 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1033 | 0.090 |
Why?
|
| Humans | 43 | 2021 | 760617 | 0.090 |
Why?
|
| Brain Waves | 1 | 2014 | 409 | 0.090 |
Why?
|
| Communication | 3 | 2020 | 3849 | 0.090 |
Why?
|
| Cerebral Cortex | 4 | 2014 | 5776 | 0.080 |
Why?
|
| Brain Death | 1 | 1992 | 357 | 0.080 |
Why?
|
| Memory | 1 | 2018 | 2192 | 0.080 |
Why?
|
| Sural Nerve | 1 | 2008 | 105 | 0.080 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2009 | 116 | 0.080 |
Why?
|
| Folic Acid | 1 | 2015 | 1323 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2019 | 2174 | 0.070 |
Why?
|
| Quality Improvement | 2 | 2020 | 3797 | 0.070 |
Why?
|
| Brain Ischemia | 3 | 2018 | 3028 | 0.070 |
Why?
|
| Triazines | 1 | 2009 | 311 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3333 | 0.070 |
Why?
|
| Valproic Acid | 1 | 2009 | 443 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2020 | 80566 | 0.060 |
Why?
|
| Anecdotes as Topic | 1 | 2005 | 56 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2009 | 539 | 0.060 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 1 | 1986 | 239 | 0.060 |
Why?
|
| Stereotaxic Techniques | 1 | 2007 | 555 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2004 | 122 | 0.060 |
Why?
|
| Strontium | 1 | 1984 | 21 | 0.060 |
Why?
|
| Barium | 1 | 1984 | 62 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2012 | 2486 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 8618 | 0.050 |
Why?
|
| Rats, Inbred Strains | 4 | 1986 | 2088 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4803 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2020 | 54360 | 0.050 |
Why?
|
| Online Systems | 1 | 2003 | 182 | 0.050 |
Why?
|
| Critical Care | 1 | 2014 | 2690 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3742 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2013 | 3567 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 2948 | 0.050 |
Why?
|
| Physicians | 2 | 2016 | 4583 | 0.050 |
Why?
|
| Sclerosis | 2 | 2016 | 210 | 0.040 |
Why?
|
| Stroke | 1 | 2002 | 9712 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2004 | 798 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 1994 | 3979 | 0.040 |
Why?
|
| Adolescent | 8 | 2020 | 88234 | 0.040 |
Why?
|
| Guinea | 1 | 2019 | 33 | 0.040 |
Why?
|
| Tetrahydropapaveroline | 1 | 1979 | 2 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1986 | 1140 | 0.040 |
Why?
|
| Papaverine | 1 | 1979 | 45 | 0.040 |
Why?
|
| Computer Security | 1 | 2001 | 260 | 0.040 |
Why?
|
| Aged | 12 | 2020 | 169042 | 0.040 |
Why?
|
| Patient Advocacy | 1 | 2001 | 360 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 8601 | 0.040 |
Why?
|
| Status Epilepticus | 1 | 2004 | 460 | 0.040 |
Why?
|
| Mass Screening | 1 | 2014 | 5424 | 0.040 |
Why?
|
| Quality of Life | 4 | 2020 | 13347 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1984 | 2185 | 0.040 |
Why?
|
| Anxiety | 1 | 2012 | 4570 | 0.040 |
Why?
|
| Confidentiality | 1 | 2001 | 608 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2005 | 1125 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2018 | 463 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 14018 | 0.030 |
Why?
|
| Pregnancy | 2 | 2015 | 29868 | 0.030 |
Why?
|
| Brain Mapping | 3 | 2004 | 6634 | 0.030 |
Why?
|
| Social Support | 1 | 2005 | 2174 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 58894 | 0.030 |
Why?
|
| Meningioma | 1 | 2004 | 1215 | 0.030 |
Why?
|
| Recurrence | 2 | 2018 | 8426 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 1245 | 0.030 |
Why?
|
| Markov Chains | 1 | 2018 | 965 | 0.030 |
Why?
|
| Patient Participation | 1 | 2004 | 1443 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2004 | 2256 | 0.030 |
Why?
|
| Health Services | 1 | 2000 | 751 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 2 | 1984 | 100 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 2821 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2002 | 1695 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15612 | 0.030 |
Why?
|
| Observer Variation | 1 | 2020 | 2606 | 0.030 |
Why?
|
| Data Collection | 1 | 2003 | 3315 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 1984 | 531 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14648 | 0.030 |
Why?
|
| Brain Stem | 1 | 1978 | 858 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 894 | 0.030 |
Why?
|
| Rats | 7 | 1988 | 23717 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 8132 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 452 | 0.020 |
Why?
|
| Calcium | 2 | 1988 | 5717 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 1722 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2003 | 2053 | 0.020 |
Why?
|
| Dopamine | 1 | 1978 | 1606 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1984 | 4408 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1992 | 246 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20074 | 0.020 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1993 | 366 | 0.020 |
Why?
|
| Executive Function | 1 | 2018 | 1391 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2016 | 1835 | 0.020 |
Why?
|
| Phosphorylation | 3 | 1984 | 8311 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 2008 | 50 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1988 | 422 | 0.020 |
Why?
|
| Follicular Phase | 1 | 2009 | 143 | 0.020 |
Why?
|
| Luteal Phase | 1 | 2009 | 138 | 0.020 |
Why?
|
| Electroconvulsive Therapy | 1 | 1994 | 500 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1988 | 174 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1991 | 300 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 1998 | 0.020 |
Why?
|
| Attention | 1 | 2018 | 2396 | 0.020 |
Why?
|
| Catheterization | 1 | 1993 | 1428 | 0.020 |
Why?
|
| Self Concept | 1 | 1994 | 1046 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1185 | 0.020 |
Why?
|
| Glutamates | 1 | 1988 | 389 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39063 | 0.020 |
Why?
|
| Health Status | 1 | 2000 | 4075 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12966 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7798 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 39913 | 0.020 |
Why?
|
| Nipecotic Acids | 1 | 1986 | 36 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 1979 | 4025 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 41457 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1991 | 874 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1986 | 531 | 0.020 |
Why?
|
| Autoradiography | 1 | 1986 | 728 | 0.020 |
Why?
|
| Brain | 3 | 1996 | 27101 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2018 | 6233 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12334 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1991 | 1474 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2009 | 1415 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1984 | 116 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1992 | 1734 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1992 | 1007 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14591 | 0.010 |
Why?
|
| Ion Channels | 1 | 1988 | 1039 | 0.010 |
Why?
|
| Embolization, Therapeutic | 1 | 1993 | 1418 | 0.010 |
Why?
|
| Paresis | 1 | 2004 | 176 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 9026 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5866 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1986 | 1703 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2007 | 838 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7995 | 0.010 |
Why?
|
| Receptors, Glutamate | 2 | 1996 | 227 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1984 | 251 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 64568 | 0.010 |
Why?
|
| Critical Illness | 1 | 2014 | 2709 | 0.010 |
Why?
|
| Cognition | 1 | 2018 | 6987 | 0.010 |
Why?
|
| Clone Cells | 1 | 2004 | 1657 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9604 | 0.010 |
Why?
|
| Registries | 1 | 2016 | 8207 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1988 | 1248 | 0.010 |
Why?
|
| Neuroglia | 1 | 1986 | 955 | 0.010 |
Why?
|
| Age Factors | 1 | 2016 | 18381 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13382 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26049 | 0.010 |
Why?
|
| Appetitive Behavior | 1 | 1979 | 39 | 0.010 |
Why?
|
| Infant | 2 | 2019 | 36152 | 0.010 |
Why?
|
| Atrophy | 1 | 2004 | 1631 | 0.010 |
Why?
|
| Fetus | 1 | 1986 | 1862 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2019 | 42188 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 2381 | 0.010 |
Why?
|
| Microinjections | 1 | 1978 | 321 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1984 | 1988 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 2635 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2004 | 703 | 0.010 |
Why?
|
| Pediatrics | 1 | 2013 | 3588 | 0.010 |
Why?
|
| Animals | 7 | 1988 | 168201 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1978 | 561 | 0.010 |
Why?
|
| Excitatory Amino Acids | 1 | 1996 | 17 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1978 | 350 | 0.010 |
Why?
|
| Child | 3 | 2019 | 80079 | 0.010 |
Why?
|
| Kinetics | 1 | 1984 | 6370 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2004 | 1350 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15251 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 2008 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 4473 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2000 | 969 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2004 | 2726 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74115 | 0.010 |
Why?
|
| Gyrus Cinguli | 1 | 1979 | 1115 | 0.010 |
Why?
|
| Prognosis | 3 | 2000 | 29600 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1993 | 623 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1984 | 10754 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2009 | 12943 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2000 | 2024 | 0.010 |
Why?
|
| Mitochondria | 1 | 1984 | 3619 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 1993 | 445 | 0.010 |
Why?
|
| Vertebral Artery | 1 | 1991 | 184 | 0.010 |
Why?
|
| Neurons | 2 | 1988 | 9438 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2000 | 2016 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 915 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1988 | 35 | 0.010 |
Why?
|
| Oxadiazoles | 1 | 1988 | 94 | 0.000 |
Why?
|
| Cystine | 1 | 1988 | 94 | 0.000 |
Why?
|
| Electric Conductivity | 1 | 1988 | 405 | 0.000 |
Why?
|
| Intermediate Filament Proteins | 1 | 1988 | 262 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1988 | 1141 | 0.000 |
Why?
|
| Neurofilament Proteins | 1 | 1988 | 333 | 0.000 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1993 | 1493 | 0.000 |
Why?
|
| Radiography, Interventional | 1 | 1993 | 1120 | 0.000 |
Why?
|
| Chlorides | 1 | 1988 | 665 | 0.000 |
Why?
|
| Cerebral Angiography | 1 | 1991 | 1281 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 36402 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10505 | 0.000 |
Why?
|
| Potassium | 1 | 1988 | 1311 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 2467 | 0.000 |
Why?
|
| Sodium | 1 | 1988 | 1588 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1988 | 1175 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 6126 | 0.000 |
Why?
|
| Hypertension | 1 | 2000 | 8529 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 30016 | 0.000 |
Why?
|
| Mice | 1 | 1988 | 81368 | 0.000 |
Why?
|